MetLife's Q2 Earnings Preview: Analysts Expect 3.1% Decline in EPS

MetLife, Inc. (MET) is expected to report Q2 2025 earnings on August 6 after market close. Analysts forecast a profit of $2.21 per share, down 3.1% YoY, and $8.96 for the fiscal year, up 10.5% YoY. MET stock has grown 7.3% over the past 52 weeks and analysts have a "Strong Buy" rating with an average price target of $95.73, indicating a potential upside of 23.2% from current levels.

MetLife, Inc. (MET) is poised to release its Q2 2025 earnings on August 6, 2025, after the market closes. Analysts have forecast a profit of $2.21 per share, representing a 3.1% year-over-year (YoY) decline. For the fiscal year, analysts expect earnings of $8.96, which is a 10.5% YoY increase. Over the past 52 weeks, MET stock has appreciated by 7.3%, and analysts have a "Strong Buy" rating with an average price target of $95.73, indicating a potential upside of 23.2% from current levels.

In the first quarter of 2025, MetLife reported earnings per share (EPS) of $1.96, missing the consensus estimate of $2.00 by $0.04. Quarterly revenue rose 15.6% year-over-year to $18.57 billion, surpassing the consensus estimate of $18.06 billion. The company's earnings are expected to grow by 9.53% next year, from $9.65 to $10.57 per share [1].

MetLife also announced a quarterly dividend of $0.5675 per share, payable on September 9, 2025, to stockholders of record on August 5, 2025. The dividend represents an annualized payout of $2.27 and a dividend yield of 2.92%. Analysts expect MetLife to earn $10.57 per share next year, which means the company should continue to be able to cover its dividend with an expected future payout ratio of 21.5% [2].

Several research firms have weighed in on MET. Piper Sandler, JPMorgan Chase & Co., Morgan Stanley, and Wells Fargo & Company have all boosted their price targets for MET, while Keefe, Bruyette & Woods has lowered its target. The company has a market cap of $52.13 billion and a price-to-earnings ratio of 12.63. Analysts have rated the stock with an average rating of "Moderate Buy" and an average target price of $95.58 [2].

MetLife's stock has seen increased institutional ownership, with hedge funds and other institutional investors owning 94.99% of the shares. The company has initiated a stock repurchase plan, authorizing the purchase of up to $3.00 billion in shares, indicating that management believes its shares are undervalued [2].

References:
[1] https://www.marketbeat.com/earnings/reports/2025-7-30-metlife-inc-stock/
[2] https://www.marketbeat.com/instant-alerts/metlife-inc-nysemet-to-issue-quarterly-dividend-of-057-2025-07-08/